NSE APOLLOHOSP · BSE 508869 · Healthcare Facilities · NIFTY 50

Apollo Hospitals Enterprise Share Price

Market open · updated 25 Sep, 2:22 PM IST

₹8,960.00 ▼ −₹116.18 · 1.28% NSE · as of 24 Sep 2026, 8:29 AM · BSE ₹8,944.50

Today's range

₹8,944.50Low₹9,069.00High

52-week range

₹6,680.00Low · 23 Jan 2026₹9,326.80High · 23 Sep 2026

Apollo Hospitals Enterprise Overview

Where the price stands, how it has moved and how it sits against its averages.

Apollo Hospitals Enterprise shares last traded at ₹8,960.00 on the NSE, down 1.28% on the day. That is 3.9% below the 52-week high of ₹9,326.80 and 34.1% above the 52-week low of ₹6,680.00. The stock trades at 59.74× earnings, above the sector average of 30.42. Its market value is ₹1,28,608 Cr.

Price returns

1 Day▼ −1.28%

5 Days▲ +4.28%

This month▲ +1.92%

3 Months▲ +5.78%

6 Months▲ +19.64%

This year▲ +28.78%

1 Year▲ +18.02%

Against the market: 1 Month ▲ +7.11% · 3 Months ▲ +8.84% · 6 Months ▲ +20.35% · This year ▲ +46.66% · 1 Year ▲ +29.50%

Shading grows with the size of the move. Prices refresh every 15 minutes while the market is open (9:15 AM–3:30 PM IST).

Moving averages — price is above 6 of 6

Today's price₹8,960.00
10-day average₹8,841.15 ▲ price 1.3% above
50-day average₹8,836.33 ▲ price 1.4% above
5-day average₹8,831.40 ▲ price 1.5% above
20-day average₹8,806.10 ▲ price 1.7% above
100-day average₹8,580.08 ▲ price 4.4% above
300-day average₹7,952.69 ▲ price 12.7% above

Averages above today's price sit higher on the ladder. Price above most of its averages is usually read as an upward trend.

Apollo Hospitals Enterprise Financial Results

Revenue and net profit in ₹ crore, with the full statements underneath.

Revenue₹ crore

25,229

Net profit₹ crore · losses below zero

1,942

Year by year

Fiscal year	Revenue	Growth	Net profit	Net margin	EPS	Dividend
FY 2026	₹25,229 Cr	▲ +15.8%	₹1,942 Cr	7.7%	₹134.95	₹20.00
FY 2025	₹21,794 Cr	▲ +14.3%	₹1,446 Cr	6.6%	₹100.56	₹19.00
FY 2024	₹19,059 Cr	▲ +14.7%	₹899 Cr	4.7%	₹62.50	₹16.00
FY 2023	₹16,613 Cr	▲ +13.3%	₹819 Cr	4.9%	₹56.97	₹15.00
FY 2022	₹14,663 Cr	▲ +38.9%	₹1,056 Cr	7.2%	₹73.42	₹11.75
FY 2021	₹10,560 Cr	▼ −6.1%	₹150 Cr	1.4%	₹10.74	₹3.00
FY 2020	₹11,247 Cr	—	₹455 Cr	4.0%	₹32.69	₹6.00

Revenue₹ crore

7,044

Net profit₹ crore · losses below zero

581

Quarter by quarter

Quarter	Revenue	vs prev. qtr	Net profit	Net margin	EPS
Q1 FY27	₹7,044 Cr	▲ +6.6%	₹581 Cr	8.2%	₹40.37
Q4 FY26	₹6,606 Cr	▲ +2.0%	₹529 Cr	8.0%	₹36.71
Q3 FY26	₹6,477 Cr	▲ +2.8%	₹502 Cr	7.8%	₹34.94
Q2 FY26	₹6,304 Cr	▲ +7.9%	₹477 Cr	7.6%	₹33.19
Q1 FY26	₹5,842 Cr	▲ +4.5%	₹433 Cr	7.4%	₹30.10
Q4 FY25	₹5,592 Cr	▲ +1.2%	₹390 Cr	7.0%	₹27.10
Q3 FY25	₹5,527 Cr	▼ −1.1%	₹372 Cr	6.7%	₹25.89
Q2 FY25	₹5,589 Cr	—	₹379 Cr	6.8%	₹26.34

Balance sheet — FY26

Owes (liabilities)Shareholders' equity

57%

43%

Total assets₹22,197 Cr
Total liabilities₹12,717 Cr
Shareholders' equity₹9,480 Cr
Total debt₹8,493 Cr
Cash & investments₹1,856 Cr
Current ratio1.06×
Revenue growth, 5 yr19.03% a year
EPS growth, 5 yr65.88% a year
Operating margin (TTM)11.71%
Net margin (TTM)8.05%

Cash flow — FY26

Operating activities

▲ ₹2,859 Cr

Investing activities

▼ −₹2,148 Cr

Financing activities

▼ −₹478 Cr

Free cash flow

▲ ₹897 Cr

Net change in cash

▲ ₹233 Cr

Right of the line = cash coming in, left = cash going out. Free cash flow = cash from operations minus capital spending.

Full financial statements, FY20–FY26

₹ crore	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Total revenue	11,246.80	10,560.00	14,662.60	16,612.50	19,059.20	21,794.00	25,228.50
Cost of revenue	5,498.90	5,684.20	7,573.50	8,574.30	9,805.50	11,310.00	13,075.60
Gross profit	5,747.90	4,875.80	7,089.10	8,038.20	9,253.70	10,484.00	12,152.90
Operating expenses	10,072.10	9,920.60	12,778.30	15,160.20	17,348.00	19,516.00	22,343.50
Operating income	1,174.70	639.40	1,884.30	1,452.30	1,711.20	2,278.00	2,885.00
Depreciation	619.10	572.50	600.10	614.80	686.40	756.90	875.40
Profit before tax	660.00	220.70	1,578.10	1,143.70	1,362.50	2,006.10	2,616.00
Tax	225.20	84.70	477.00	256.20	445.50	534.00	658.20
Net profit	454.80	150.40	1,055.60	819.10	898.60	1,445.90	1,941.70
EPS (₹)	32.69	10.74	73.42	56.97	62.50	100.56	134.95
Dividend per share (₹)	6.00	3.00	11.75	15.00	16.00	19.00	20.00

₹ crore	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Total assets	11,338.40	11,416.70	13,269.30	14,427.80	16,753.10	20,657.40	22,196.90
Current assets	2,646.90	3,641.30	4,060.60	4,337.00	5,279.70	7,028.90	6,899.80
Cash & short-term investments	472.90	1,530.20	1,157.10	880.00	1,358.20	2,010.30	1,855.90
Inventory	817.90	327.60	523.00	516.70	622.50	671.50	640.00
Property, plant & equipment	7,260.90	6,545.70	7,288.60	8,033.80	9,385.20	10,586.70	12,030.10
Total liabilities	7,999.30	6,814.20	7,646.00	8,230.40	9,817.70	12,445.10	12,716.80
Current liabilities	2,337.30	2,037.80	2,434.30	3,324.90	4,664.50	4,578.90	6,481.30
Total debt	5,620.70	4,159.70	4,068.10	4,332.40	5,332.60	7,864.30	8,492.90
Total equity	3,339.10	4,602.50	5,623.30	6,197.40	6,935.40	8,212.30	9,480.10

₹ crore	FY20	FY21	FY22	FY23	FY24	FY25	FY26
From operations	1,292.80	1,256.90	1,796.60	1,390.50	1,920.30	2,136.40	2,859.00
From investing	−288.80	−872.30	−847.20	−870.60	−1,537.20	−3,380.60	−2,148.20
From financing	−909.50	−340.10	−791.60	−633.00	−311.10	1,316.80	−477.60
Capital expenditure	−513.00	−295.50	−657.20	−1,128.50	−1,136.80	−1,712.70	−1,962.00
Dividends paid	−155.10	−38.30	−43.30	−255.20	−215.70	−273.20	−287.60
Net change in cash	94.50	44.50	157.80	−113.10	72.00	72.60	233.20

What Analysts Say

27 analysts

Recommendations from 27 analysts who cover Apollo Hospitals Enterprise.

Strong Buy average rating 1.74 on a 1–5 scale

Strong buyBuyHoldSellStrong sell

▲ 23 bullish (85.2%) · 3 hold (11.1%) · ▼ 1 bearish (3.7%)

Votes

Strong Buy

12 (44%)

Buy

11 (41%)

Hold

3 (11%)

Sell

1 (4%)

Strong Sell

0 (0%)

How the votes changed

Rating	3M ago	2M ago	1M ago	1W ago	Now	3-month change
Strong Buy	11	12	12	12	12	▲ +1
Buy	11	11	11	11	11	—
Hold	3	3	3	3	3	—
Sell	1	1	1	1	1	—
Strong Sell	0	0	0	0	0	—

Analyst ratings are opinions, not a guarantee of returns.

Apollo Hospitals Enterprise vs Peers

Side by side with other healthcare facilities companies. The small bars compare each column.

Company	Price	Change	Market cap	P/E	P/B	ROE (5 yr)	Net margin	Div. yield	Rating
Apollo Hospitals Enterprise	₹8,960.00	▼ −1.28%	₹1,28,608 Cr	59.74	13.75	18.12%	8.05%	0.22%	This stock
Max Healthcare Institute	₹1,046.05	▼ −0.62%	₹1,01,813 Cr	71.47	9.87	13.32%	17.23%	0.18%	Neutral
Fortis Healthcare	₹885.00	▼ −0.67%	₹66,814 Cr	67.89	7.27	9.36%	11.66%	0.10%	Bearish
Aster DM Healthcare	₹769.65	▲ +1.20%	₹67,173 Cr	102.55	9.26	7.13%	9.20%	0.49%	Neutral
Narayana Hrudayalaya	₹1,881.60	▼ −2.08%	₹38,373 Cr	48.07	9.08	25.72%	10.26%	0.22%	Moderately Bearish
Global Health	₹1,505.05	▲ +0.64%	₹40,628 Cr	63.65	8.93	15.69%	12.56%	0.04%	Bullish

Rating = the data provider's overall technical view of each peer. Company names link to their own pages.

Shareholding Pattern

Who owns Apollo Hospitals Enterprise shares, quarter by quarter (latest on top).

PromoterFIIMFOther

Jun '26

28.0%

41.5%

17.3%

13.2%

Mar '26

Dec '25

Sep '25

Holder	Sep '25	Dec '25	Mar '26	Jun '26	Change
Promoter	28.02%	28.02%	28.02%	28.02%	0.00 pts
FII	44.20%	43.54%	42.62%	41.49%	▼ −1.13 pts
MF	16.48%	16.75%	16.65%	17.33%	▲ +0.68 pts
Other	11.30%	11.69%	12.71%	13.16%	▲ +0.45 pts

Apollo Hospitals Enterprise Key Metrics

Each ratio placed against a benchmark — the sector average, the company's own 5-year average, or a common rule of thumb.

Apollo Hospitals EnterpriseBenchmarkComfortable → stretched

Valuation Is the price reasonable?

P/E (TTM)Price ÷ yearly earnings per share

59.74

▲ 96% above the sector average of 30.42

P/E, 12-month rangeLow 54.98 · high 109.63

Today's P/E sits 9% of the way from its low to its high

P/BPrice ÷ book value per share

13.75

P/SPrice ÷ sales per share

4.93

P/CFPrice ÷ cash flow per share

43.12

PEGP/E ÷ earnings growth (≈1 is fair)

1.88

Profitability Of every ₹100 of sales, how much is kept?

Gross marginKept after the cost of goods

48.45%

▲ above its 5-yr average of 48.29%

Operating marginKept after running costs

11.71%

▲ above its 5-yr average of 10.49%

Pre-tax marginKept before tax

10.72%

▲ above its 5-yr average of 8.94%

Net marginKept as profit

8.05%

▲ above its 5-yr average of 6.51%

Returns & efficiency How well does it use its money?

Return on equityProfit on shareholders' money

21.95%

▲ above its 5-yr average of 18.12%

Return on assetsProfit on everything it owns

9.14%

▲ above its 5-yr average of 7.73%

Return on investmentProfit on long-term capital

12.69%

▲ above its 5-yr average of 10.41%

Growth Is the business getting bigger?

Revenue — last 12 months

+17.2%

▲ growing

Revenue — 3 yr, a year

+14.9%

▲ growing

Revenue — 5 yr, a year

+19.0%

▲ growing

EPS — last 12 months

+32.7%

▲ growing (off the scale)

EPS — 3 yr, a year

+33.3%

▲ growing (off the scale)

EPS — 5 yr, a year

+65.9%

▲ growing (off the scale)

Dividend — 3 yr, a year

+10.1%

▲ growing

Book value — 5 yr, a year

+15.6%

▲ growing

Financial strength Can it pay its bills and debts?

Debt to equityBorrowings for every ₹1 of shareholders' money

0.90×

• Moderate

Current ratioShort-term assets for every ₹1 due within a year

1.06×

• Adequate

Quick ratioLike the current ratio, without inventory

0.97×

• Adequate

Interest coverOperating profit ÷ interest to pay

14.91×

✓ Strong

Payout ratioShare of profit paid as dividend

14.81%

• Keeps most

Per share What each share stands for

EPS (TTM)

₹145.21

Book value

₹659.26

Cash flow

₹210.14

Dividend

₹20.00

Revenue

₹1,836.73

The share price is 13.59× the book value behind each share.

Benchmarks: sector averages and 5-year averages come from the data provider; the debt and liquidity bands are common rules of thumb, not investment advice.

All 112 metrics from the data provider

Valuation

P/E excluding extraordinary items, most recent fiscal year67.20

Current Dividend Yield - Common Stock Primary Issue, LTM0.22

Price to Book - most recent fiscal year13.75

P/E Basic excluding extraordinary items - TTM59.74

P/E including extraordinary items - TTM62.45

P/E excluding extraordinary items low, trailing 12 months54.98

Price to Tangible Book - most fiscal year15.89

Dividend Yield - 5 Year Average0.28

Price to sales - most recent fiscal year5.17

Dividend Yield - indicated annual dividend divided by closing price0.22

Price to Cash Flow per share - trailing 12 month43.12

Peg Ratio1.88

Price to Free Cash Flow per Share - most recent fiscal year213.98

P/E Normalized, most recent fiscal year66.50

P/E excluding extraordinary items high, trailing 12 months109.63

P/E excluding extraordinary items, most recent fiscal year quarter62.45

Price to sales - trailing 12 month4.93

Net Debt, LFY66,370.00

Per share

Dividend Per Share - 5 year average16.35

Cash Flow per share - trailing 12 month210.14

Cash Flow per share - most recent fiscal year196.91

EPS including extraordinary items - trailing 12 month145.21

EPS including extraordinary items - most recent fiscal year134.95

EBITD per share - trailing 12 month278.64

Revenue/share - trailing 12 month1,836.73

EPS excluding extraordinary items - trailing 12 month145.21

EPS Basic excluding extraordinary items - most recent fiscal year135.04

EPS Basic excluding extraordinary items - trailing 12 month145.33

Book value per share - most recent fiscal year659.33

Dividend per share - most recent fiscal year20.00

Revenue/share - most recent fiscal year1,753.42

EPS Normalized - most recent fiscal year136.37

Book value (tangible) per share - most recent fiscal year570.88

Dividends per share - trailing 12 month20.00

EPS excluding extraordinary items - most recent fiscal year134.95

Cash per share - most recent fiscal year129.08

Margins

Operating margin - trailing 12 month11.71

Gross Margin - 5 year average48.29

Operating margin - 1st historical fiscal year11.44

Operating Margin - 5 year average10.49

Net Profit Margin % - 1st historical fiscal year7.76

Gross Margin - 1st historical fiscal year48.17

Net Profit Margin % - trailing 12 month8.05

Net Profit Margin - 5 year average6.51

Pretax Margin - 5 year average8.94

Pretax margin - 1st historical fiscal year10.37

Pretax margin - trailing 12 month10.72

Free Operating Cash Flow/Revenue, 5 Year Average2.50

Gross Margin - trailing 12 month48.45

Growth

EPS Change %, TTM over TTM32.70

Revenue growth rate, 5 year19.03

EPS growth rate, 5 year65.88

Revenue Change % - most recent quarter 1 year ago20.56

Growth rate% - dividend, 3 year10.06

Growth rate% - EPS, 3 year33.31

Revenue/share (5 yr growth)18.38

Free Operating Cash Flow, 5 Year CAGR−7.97

Tangible Book Value, Total Equity, 5 Year CAGR14.66

Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year Interim CAGR19.84

Capital Spending growth rate, 5 year46.03

Revenue Change %, TTM over TTM17.20

Growth rate% - Revenue, 3 year14.94

Book value per share growth rate, 5 year15.55

EPS Change % - most recent quarter 1 year ago34.12

Net Profit Margin growth rate, 5 year43.22

Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR26.83

Total Debt, 5 Year CAGR15.35

Financial strength

Net Interest coverage - most recent fiscal year14.91

Free Cash Flow - most recent fiscal year6,094.00

LT debt/equity - most recent fiscal year0.54

Quick ratio - most recent fiscal year0.97

Payout ratio - trailing 12 month6.88

Current ratio - most recent fiscal year1.06

Current EV/Free Cash Flow, LFY235.66

Total debt/total equity - most recent fiscal year0.90

Net Interest coverage - trailing 12 month6.74

Payout ratio - most recent fiscal year14.81

Returns & efficiency

Return on average equity - 5 year average18.12

Net Income/employee - trailing 12 month4,83,412.10

Revenue/employee - most recent fiscal year58,32,842.00

Return on investment - most recent fiscal year12.69

Return on average assets - most recent fiscal year9.14

Receivables turnover - most recent fiscal year7.33

Inventory turnover - most recent fiscal year19.94

Revenue/employee - trailing 12 month60,05,704.00

Return on average assets - 5 year average7.73

Net Income/employee - most recent fiscal year4,52,644.30

Asset turnover - most recent fiscal year1.18

Return on average equity - most recent fiscal year21.95

Return on investment - 5 year average10.41

Price & volume

Market Cap1,29,025.16

52 week Low Date23 Jan 2026

Price - 1 Day % Change2.64

Relative (S&P500) price percent change - 13 week8.84

Avg trading volume last 10 days0.29

Price - 13 week price percent change5.78

Price - 52 week price percent change18.02

Avg Trading Volume Last 3 months6.74

Price - 5 Day % Change4.28

Price % Change Month To Date1.92

Relative (S&P500) price percent change - 04 week7.11

52 week High Date23 Sep 2026

Price - 26 week price percent change19.64

PDATE23 Sep 2026

Price - YTD price percent change28.78

Relative (S&P500) price percent change - 52 week29.50

NPRICE9,069.00

Relative (S&P500) price percent change - 26 week20.35

52 week Low6,696.50

52 week High9,070.50

Beta0.60

Relative (S&P500) price percent change - Year to Date46.66

Dividends & Corporate Events

Payouts to shareholders, splits and bonus issues, and company meetings — newest first.

Dividend per share₹ per share, by fiscal year

₹20.00

Dividend yield0.22%
Payout ratio14.81%
5-year average dividend₹16.35 a share
Latest dividend₹10.00 per share · 14 Aug 2026

Corporate calendar

25 Aug 2026MeetingAnnual General Meeting
25 Aug 2026MeetingAnnual General Meeting
14 Aug 2026Dividend₹10.00 per share · 200% · Final dividend
12 Aug 2026BoardQuarterly Results
24 Jun 2026MeetingCOM
20 May 2026BoardAudited Results & Final Dividend
16 Feb 2026Dividend₹10.00 per share · 200% · Interim dividend
10 Feb 2026BoardQuarterly Results, Int. Dividend & Others

Show 14 older events

6 Nov 2025BoardQuarterly Results
29 Aug 2025MeetingAnnual General Meeting
19 Aug 2025Dividend₹10.00 per share · 200% · Final dividend
12 Aug 2025BoardQuarterly Results & Others
30 May 2025BoardAudited Results, Final Dividend & A.G.M.
14 Feb 2025Dividend₹9.00 per share · 180% · Interim dividend
10 Feb 2025BoardQuarterly Results & Interim Dividend
6 Nov 2024BoardQuarterly Results
30 Aug 2024MeetingAnnual General Meeting
19 Aug 2024MeetingPostal Ballot
16 Aug 2024Dividend₹10.00 per share · 200% · Final dividend
20 Feb 2024Dividend₹6.00 per share · 120% · Interim dividend
18 Aug 2023Dividend₹9.00 per share · 180% · Final dividend
24 Feb 2023Dividend₹6.00 per share · 120% · Final dividend

About Apollo Hospitals Enterprise

Healthcare Facilities

Apollo Hospitals Enterprise Limited is an integrated healthcare company. It is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. It is engaged in hospitals and hospitals-based services. The Company's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. The Retail Health and Diagnostics segment include clinics, diagnostics, Spectra, Cradle, Sugar, Dental and Dialysis business. The Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast-moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,100 plus beds across 73 hospitals and 6,600 plus pharmacies.

Key people

Prathap C. ReddyExecutive Chairman of the Board, Founder
Preetha ReddyExecutive Vice Chairman of the Board
Krishnan AkhileswaranChief Financial Officer
Sankaranarayan Muthu KrishnanSenior Vice President - Finance, Company Secretary
Sangita ReddyJoint Managing Director, Executive Director
Suneeta ReddyManaging Director, Executive Director

Company facts

NSE symbolAPOLLOHOSP
BSE code508869
ISININE437A01024
IndustryHealthcare Facilities
IndexNIFTY 50, NIFTY 500
Market cap₹1,28,608 Cr
Revenue (FY26)₹25,229 Cr
Net profit (FY26)₹1,942 Cr

In the News

Recent headlines about Apollo Hospitals Enterprise — they open on Mint in a new tab.

Doctors push for AI in Indian healthcare—from smart ICUs to smarter diagnoses
Doctors are pushing for AI to not only improve productivity and diagnosis but also address issues including second opinions, faster test results and quicker access to doctors, freeing up their time to see more patients.
23 Sep 2026 · 5 min read · Mint ↗
Stock market today: Gift Nifty hints a weak start; eight day trading stocks to buy on Monday, 17 August
Indian stock indices Sensex and Nifty 50 are set to open lower on August 17 due to weak global signals. The Gift Nifty indicated a subdued start, trading below previous closes. Geopolitical tensions and oil prices remain critical factors affecting market sentiment.
17 Aug 2026 · 4 min read · Mint ↗
Apollo Hospitals beats estimates for Q1FY27, net profit up 34%
Apollo Hospitals' Q1FY27 net profit rose 34% to ₹581 crore, beating street estimates, as high-complexity specialty volumes and pharmacy growth lifted revenue 21% to ₹7,043 crore.
12 Aug 2026 · 1 min read · Mint ↗
Sensex falls 388 points, Nifty 50 ends below 24,500; rising oil prices, Middle East confusion weigh
The Sensex fell 388 points, or 0.49%, to end at 78,154, while the Nifty 50 settled 112 points, or 0.46%, lower at 24,472. Nifty Midcap 100 index slipped 0.02%, while the Smallcap 100 index rose 0.22%.
11 Aug 2026 · 2 min read · Mint ↗
Stocks to buy for short term: Mahindra and Mahindra among 3 shares Amol Athawale of Kotak Securities recommends
Amol Athawale from Kotak Securities identifies three stocks with growth potential, including Mahindra and Mahindra. With key support levels and upward momentum indicated by technical analysis, now appears to be the time to pay attention to these market movers.
23 Jul 2026 · 2 min read · Mint ↗
Stock market today: Sensex jumps 500 points, Nifty 50 closes above 24,400; investors earn ₹2 lakh crore in a day
The Sensex ended 521 points, or 0.67%, higher at 78,285, while the Nifty 50 closed at 24,430, up 160 points, or 0.66%. The mid and small-cap segments also rose. The Nifty Midcap 100 and Smallcap 100 indices gained 0.45% and 0.75%, respectively.
6 Jul 2026 · 4 min read · Mint ↗
Stock market today: Sensex gains 260 points, Nifty 50 ends above 24,250; IT, pharma shine
Stock market today: The Sensex ended 262 points, or 0.34%, higher at 77,763.91, while the Nifty 50 rose by 95 points, or 0.39%, to end at 24,270.85.
3 Jul 2026 · 4 min read · Mint ↗
Doctor-led Magnet Hospitals debuts, signs up 8 hospitals
Magnet Hospitals, has debuted with an initial portfolio of eight city hospitals. The platform is backed by an initial investment of ₹224 crore, funded by Madhavan as the primary investor.
1 Jul 2026 · 1 min read · Mint ↗

Stock data comes from the exchange feed via our data provider and may be delayed. It is for information only and is not a recommendation to buy or sell. See all stocks →

Frequently Asked Questions

Apollo Hospitals Enterprise (NSE: APOLLOHOSP) last traded at ₹8,960.00 on the NSE, down 1.28% (₹116.18) on the day, as of 24 Sep 2026, 8:29 AM. On the BSE it was ₹8,944.50. The day's range was ₹8,944.50 – ₹9,069.00.

Apollo Hospitals Enterprise's 52-week high is ₹9,326.80 (23 Sep 2026) and its 52-week low is ₹6,680.00 (23 Jan 2026). At ₹8,960.00 the share is 3.9% below its high and 34.1% above its low.

Apollo Hospitals Enterprise's market capitalisation is ₹1,28,608 Cr (₹1.29L Cr). It is part of the NIFTY 50 index.

Apollo Hospitals Enterprise's P/E ratio (trailing 12 months) is 59.74. The sector average is 30.42, so investors pay 96% more for each rupee of its earnings than for the average company in its sector. Its earnings per share (TTM) are ₹145.21.

Apollo Hospitals Enterprise shares are up 18.02% over the last year, up 28.78% so far this year, up 19.64% over 6 months, up 5.78% over 3 months. Over the last year the stock did 29.50% better than the market.

In FY26 (year to Mar 2026), Apollo Hospitals Enterprise reported revenue of ₹25,229 Cr (up 15.76% on the year before) and a net profit of ₹1,942 Cr. Earnings per share were ₹134.95.

Yes. Apollo Hospitals Enterprise's latest dividend is ₹10.00 per share (200%, final dividend), with an ex-date of 14 Aug 2026. The dividend yield is 0.22%. It has paid 8 dividends in the records shown on this page.

Of 27 analysts covering Apollo Hospitals Enterprise, 23 are bullish (12 strong buy, 11 buy), 3 say hold and 1 are bearish. The consensus is Strong Buy (average rating 1.74 on a scale where 1 is Strong Buy and 5 is Strong Sell). Analyst views are opinions, not a guarantee.

As of Jun 2026: Promoter 28.02%, FII 41.49%, MF 17.33%, Other 13.16%.

Apollo Hospitals Enterprise's listed peers in Healthcare Facilities include Max Healthcare Institute, Fortis Healthcare, Aster DM Healthcare, Narayana Hrudayalaya, Global Health. By market capitalisation it ranks #1 of 6 in this group.

Price returns

Moving averages — price is above 6 of 6

Year by year

Quarter by quarter

Balance sheet — FY26

Cash flow — FY26

Votes

How the votes changed

Valuation Is the price reasonable?

Profitability Of every ₹100 of sales, how much is kept?

Returns & efficiency How well does it use its money?

Growth Is the business getting bigger?

Financial strength Can it pay its bills and debts?

Per share What each share stands for

Valuation

Per share

Margins

Growth

Financial strength

Returns & efficiency

Price & volume

Corporate calendar

Key people

Company facts

Frequently Asked Questions

What is Apollo Hospitals Enterprise share price today?

What is the 52-week high and low of Apollo Hospitals Enterprise shares?

What is the market capitalisation of Apollo Hospitals Enterprise?

What is the P/E ratio of Apollo Hospitals Enterprise?

How has Apollo Hospitals Enterprise stock performed?

What were Apollo Hospitals Enterprise's latest annual results?

Does Apollo Hospitals Enterprise pay a dividend?

What do analysts recommend for Apollo Hospitals Enterprise shares?

What is the shareholding pattern of Apollo Hospitals Enterprise?

Who are Apollo Hospitals Enterprise's competitors?